Nasdaq

TXSE’s launch will spur needed competition and smooth the way for companies to go public, the strategic advisor said at the 2025 Venture Dallas conference. And, over time, he says it will help make Texas America’s ‘center for capital markets’ and become a defining chapter in the state’s economic history, alongside Spindletop and the integrated circuit.

The Irving-based leader in precision oncology—which has raised $1.86 billion since 2018—plans to raise as much as $423.5 million when it goes public on the Nasdaq Global Select Market under the ticker symbol CAI.

In June, TXSE Group announced plans to launch the Texas Stock Exchange (TXSE), focused on enabling U.S. and global companies to access U.S. equity capital markets via a “fully electronic, national securities exchange." In the months since, that's led to endless discussion of the impact of North Texas' "Y'All Street." It was capped by yesterday's announcement that the TXSE had raised over $135 million to date as it named members of TXSE's board—including former Texas Governor and former U.S. Energy Secretary Rick Perry; former SEC Commissioner Rick Roberts; and Alex Bussandri, the global head of strategy at Citadel Securities.

Mangoceuticals is aiming its mango-flavored ED drug at a “younger demographic” with colorful packaging and humorous marketing.